RhumbLine Advisers’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.8K | Buy |
9,878
+3,290
| +50% | +$8.92K | ﹤0.01% | 3766 |
|
|
2025
Q1 | $14.8K | Sell |
6,588
-649
| -9% | -$1.46K | ﹤0.01% | 3779 |
|
|
2024
Q4 | $25.3K | Sell |
7,237
-36
| -0.5% | -$126 | ﹤0.01% | 3771 |
|
|
2024
Q3 | $29.9K | Buy |
7,273
+315
| +5% | +$1.29K | ﹤0.01% | 3759 |
|
|
2024
Q2 | $25K | Buy |
6,958
+2,887
| +71% | +$10.4K | ﹤0.01% | 3831 |
|
|
2024
Q1 | $13.4K | Buy |
4,071
+162
| +4% | +$535 | ﹤0.01% | 3821 |
|
|
2023
Q4 | $9.03K | Buy |
3,909
+311
| +9% | +$718 | ﹤0.01% | 3882 |
|
|
2023
Q3 | $4.64K | Buy |
3,598
+340
| +10% | +$438 | ﹤0.01% | 3992 |
|
|
2023
Q2 | $4.3K | Buy |
+3,258
| New | +$4.3K | ﹤0.01% | 4116 |
|